Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Big Tech Firms Target Health Care Space With Cheap Sensors In Smartphones

This article was originally published in The Pink Sheet Daily

Executive Summary

Recent activities by three smartphone giants point to a potential future where the phone itself more frequently serves as a monitoring or diagnosing device, in place of external sensors. If the trend rolls on, it could have important implications for the mobile health sector.

You may also be interested in...



Smartphone Technologies Aim To Improve Access To Care And Early Disease Detection

The transformation of the smartphone into the universal medical device continues at a fast pace. The latest products that could change various health care markets come from the sixth annual Wireless Innovation Project, a competition established by the Vodafone Americas Foundation to support mobile and wireless projects designed to improve people’s lives.

Digital Health Briefs: Apple Hires Medical Sensor Experts; Glooko Partnership

Apple hires medical sensor talent. Glooko partners with Joplin Diabetes Center. NIH director praises ZioPatch study. More digital health news.

Digital Health Briefs: Google Visits CDRH; IBM Watson Business; ZioPatch Data

CDRH hosts meet-and-greet with Google X staffers. IBM creates Watson business division. iRhythm reports favorable data for its ZioPatch arrhythmia monitor. More digital health briefs.

Related Content

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

PS076933

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel